Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation

BACKGROUND: There is limited information on treatment strategies and monitoring strategies for late antibody-mediated rejection (ABMR) after kidney transplantation. METHODS: In this observational and nonrandomized study, we compared 78 patients diagnosed with late ABMR (>3 months after transplant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transplant Direct
Egile Nagusiak: Parajuli, Sandesh, Mandelbrot, Didier A., Muth, Brenda, Mohamed, Maha, Garg, Neetika, Aziz, Fahad, Redfield, Robert R., Zhong, Weixiong, Astor, Brad C., Djamali, Arjang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2017
Gaiak:
Kidney Transplantation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828696/
https://ncbi.nlm.nih.gov/pubmed/29536028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000746
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak